Annual Current Assets
$133.54 M
-$219.92 M-62.22%
December 31, 2023
Summary
- As of February 8, 2025, TBPH annual total current assets is $133.54 million, with the most recent change of -$219.92 million (-62.22%) on December 31, 2023.
- During the last 3 years, TBPH annual current assets has fallen by -$259.80 million (-66.05%).
- TBPH annual current assets is now -74.94% below its all-time high of $532.82 million, reached on December 31, 2018.
Performance
TBPH Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$116.48 M
-$2.83 M-2.37%
September 30, 2024
Summary
- As of February 8, 2025, TBPH quarterly total current assets is $116.48 million, with the most recent change of -$2.83 million (-2.37%) on September 30, 2024.
- Over the past year, TBPH quarterly current assets has dropped by -$45.21 million (-27.96%).
- TBPH quarterly current assets is now -78.20% below its all-time high of $534.22 million, reached on March 31, 2020.
Performance
TBPH Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
TBPH Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -62.2% | -28.0% |
| 3 y3 years | -66.0% | -60.8% |
| 5 y5 years | -74.9% | -70.4% |
TBPH Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -62.2% | at low | -77.2% | at low |
| 5 y | 5-year | -66.0% | at low | -78.2% | at low |
| alltime | all time | -74.9% | +846.7% | -78.2% | +725.8% |
Theravance Biopharma Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $116.48 M(-2.4%) |
| Jun 2024 | - | $119.31 M(-4.0%) |
| Mar 2024 | - | $124.29 M(-6.9%) |
| Dec 2023 | $248.46 M(-2.2%) | $133.54 M(-17.4%) |
| Sep 2023 | - | $161.69 M(-15.8%) |
| Jun 2023 | - | $192.00 M(-26.5%) |
| Mar 2023 | - | $261.34 M(-26.1%) |
| Dec 2022 | $253.94 M(+103.2%) | $353.46 M(-30.9%) |
| Sep 2022 | - | $511.72 M(+230.7%) |
| Jun 2022 | - | $154.73 M(-24.4%) |
| Mar 2022 | - | $204.64 M(-18.1%) |
| Dec 2021 | $124.95 M(+65.0%) | $249.87 M(-15.9%) |
| Sep 2021 | - | $297.17 M(-10.8%) |
| Jun 2021 | - | $333.18 M(+13.7%) |
| Mar 2021 | - | $293.07 M(-25.5%) |
| Dec 2020 | $75.72 M(+7.6%) | $393.34 M(-12.7%) |
| Sep 2020 | - | $450.72 M(-9.6%) |
| Jun 2020 | - | $498.39 M(-6.7%) |
| Mar 2020 | - | $534.22 M(+57.8%) |
| Dec 2019 | $70.34 M | $338.49 M(-4.8%) |
| Sep 2019 | - | $355.65 M(-16.5%) |
| Jun 2019 | - | $426.04 M(-8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $467.23 M(-12.3%) |
| Dec 2018 | $27.41 M(-56.2%) | $532.82 M(+60.2%) |
| Sep 2018 | - | $332.61 M(-14.0%) |
| Jun 2018 | - | $386.69 M(-13.5%) |
| Mar 2018 | - | $446.82 M(+18.0%) |
| Dec 2017 | $62.65 M(-43.4%) | $378.75 M(+3.2%) |
| Sep 2017 | - | $367.13 M(-4.6%) |
| Jun 2017 | - | $384.88 M(-8.7%) |
| Mar 2017 | - | $421.50 M(-20.2%) |
| Dec 2016 | $110.75 M(+76.8%) | $528.50 M(+92.9%) |
| Sep 2016 | - | $274.04 M(-9.6%) |
| Jun 2016 | - | $303.13 M(+27.0%) |
| Mar 2016 | - | $238.75 M(+0.5%) |
| Dec 2015 | $62.64 M(+0.4%) | $237.47 M(-0.3%) |
| Sep 2015 | - | $238.24 M(-8.4%) |
| Jun 2015 | - | $260.23 M(-5.6%) |
| Mar 2015 | - | $275.56 M(+0.1%) |
| Dec 2014 | $62.40 M(+463.6%) | $275.37 M(-10.2%) |
| Sep 2014 | - | $306.71 M(-19.9%) |
| Jun 2014 | - | $382.73 M(+2353.4%) |
| Mar 2014 | - | $15.60 M(+10.6%) |
| Dec 2013 | $11.07 M | $14.11 M |
FAQ
- What is Theravance Biopharma annual total current assets?
- What is the all time high annual current assets for Theravance Biopharma?
- What is Theravance Biopharma annual current assets year-on-year change?
- What is Theravance Biopharma quarterly total current assets?
- What is the all time high quarterly current assets for Theravance Biopharma?
- What is Theravance Biopharma quarterly current assets year-on-year change?
What is Theravance Biopharma annual total current assets?
The current annual current assets of TBPH is $133.54 M
What is the all time high annual current assets for Theravance Biopharma?
Theravance Biopharma all-time high annual total current assets is $532.82 M
What is Theravance Biopharma annual current assets year-on-year change?
Over the past year, TBPH annual total current assets has changed by -$219.92 M (-62.22%)
What is Theravance Biopharma quarterly total current assets?
The current quarterly current assets of TBPH is $116.48 M
What is the all time high quarterly current assets for Theravance Biopharma?
Theravance Biopharma all-time high quarterly total current assets is $534.22 M
What is Theravance Biopharma quarterly current assets year-on-year change?
Over the past year, TBPH quarterly total current assets has changed by -$45.21 M (-27.96%)